56th Annual Meeting
Tentative Program Schedule
Please note that this schedule is subject to change. The Program Book distributed at the Annual Meeting will have final information on dates, times, and speakers for each presentation.


New Research Poster 5 (open)
New Research Poster Session 5

Friday, October 31, 2008: 3:30 PM-6:00 PM
River Exhibition Hall
Level 1
Sheraton Chicago Hotel & Towers
 
5.1
Effectiveness of Six Core Strategies in Reducing Seclusions and Restraints in Inpatient Child and Adolescent Psychiatric Hospital
Muhammad Waqar Azeem, M.D. Riverview Hospital for Children and Youth; Yale Child Study Center, Middletown, CT
Michelle Ramerth, R.N.
Gary Binsfeld, M.A.
Robert Jones, M.D.
 
5.2
Escitalopram in the Treatment of Adolescent Depression
Graham J. Emslie, M.D. University of Texas Southwestern Medical Center at Dallas, Dallas, TX
Ivan Gergel, M.D.
Anjana Bose, Ph.D. Harborside Financial Center, Jersey City, NJ
Daniel Ventura, Ph.D. Forest Research Institute, Jersey City, NJ
Stavros Tourkodimitiris, Ph.D.
 
5.3
Body Mass Index in Pediatric Patients and Use of Atypical Antipsychotics
Renee Washington-Hyde, M.D. , Port Washington, NY
Pavlos Kymissis, M.D. , Manhasset Hills, NY
Douglas Waite, M.D. Children's Village, Dobbs Ferry, NY
Barbara Orlowski, Ph.D. Westchester Medical Center/New York Medical Center, Westchester, NY
 
5.4
An Open-Label Trial of Aripiprazole in Youths with Autism Spectrum Disorders
Janine E. Terry, B.A. Cambridge Health Alliance, Child and Adolescent Neuropsychiatric Research Program, Medford, MA
Joseph A. Jackson, D.O. , Somerville, MA
Janis Breeze, M.P.H.
Jean Frazier, M.D. Cambridge Health Alliance, Cambridge, MA
 
5.5
Atomoxetine as an Adjunct Therapy in Treatment of Comorbid ADHD in Children and Adolescents with Bipolar I or II Disorder
Kiki Chang, M.D. Stanford University School of Medicine, Stanford, CA
Daphne K. Nayar, B.A. Stanford University, Palo Alto, CA
Manasi Rana, M.D. , Palo Alto, CA
Meghan E. Howe, M.S.W. Stanford University, Stanford, CA
 
5.6
Neurochemical Effects of Quetiapine in Youth with Bipolar Depression
Kiki Chang, M.D. Stanford University School of Medicine, Stanford, CA
Melissa P. DelBello, M.D. University of Cincinnati College of Medicine, Cincinnati, OH
Meghan E. Howe, M.S.W. Stanford University, Stanford, CA
Neil P. Mills, B.S.
Ryan Kelley, B.A. Stanford University, Stanford, CA
Holly Bryan, B.A.
Caleb Adler, M.D. University of Cincinnati, Cincinnati, OH
Manasi Rana, M.D. , Palo Alto, CA
Daniel Spielman, Ph.D.
Stephen M. Strakowski, M.D.
 
5.7
Bold Response to Presentation of Emotional Faces Differentiates Children with Bipolar Disorder from Healthy Controls
Tiffany R. Farchione, M.D. Western Psychiatric Institute and Clinic, Pittsburgh, PA
Cecile Ladouceur, Ph.D. Western Psychiatric Institute and Clinic, Pittsburgh, PA
Stefanie Hassel, Ph.D. Western Psychiatric Institute and Clinic, Pittsburgh, PA
Mary Kay Gill, M.S.
David Axelson, M.D. Western Psychiatric Institute and Clinic, Pittsburgh, PA
Boris Birmaher, M.D. Western Psychiatric Institute and Clinic, Pittsburgh, PA
Mary L. Phillips, M.D.
 
5.8
Brain Pathways in Impulsive Aggressive Male Youth in Relation to Measures for Aggression
Guido K.W. Frank, M.D. University of Colorado Denver, Aurora, CO
Lacy A. Olson, B.A.
Lucie Vaculikova
Aubree Papaj
Tony Yang, M.D. , San Diego, CA
 
5.9
Brainstem Volumetric Alterations in Children with Autism
Roger J. Jou, M.D., M.P.H. Yale Child Study Center, New Haven, CT
Matcheri S. Keshavan, M.D. Wayne State University School of Medicine, Detroit, MI
Antonio Y. Hardan, M.D. Stanford University, School of Medicine, Stanford, CA
 
5.10
Cortical Thickness Abnormalities in Pediatric Bipolar Disorder
Melissa Lopez-Larson, M.D. Cambridge Health Alliance, Medford, MA
Steve Hodge, M.A.
Janis Breeze, M.P.H.
Johnathon Kaiser, B.S.
David N. Kennedy, Ph.D.
Constance Moore, Ph.D. , Belmont, MA
Nikolaos Makris, M.D., Ph.D. , Charlestown, MA
Verne Caviness, D. Phil., M.D.
Jean Frazier, M.D. Cambridge Health Alliance, Cambridge, MA
 
5.11
Gray Matter Abnormalities in Young Male Adults with ADHD: A 3-D MRI Study
Andrea G. Ludolph, M.D. University Hospital of Ulm, Germany, Ulm Germany
Jan Kassubek, M.D.
Freimuth Juengling, M.D.
Felix M. Mottaghy, M.D.
Klaus Schmeck, M.D. Department of Child and Adolescent Psychaitry, Psychiatric University Hospital Basel, Basel Switzerland
Jorg Fegert, M.D., Ph.D. University of Ulm Hospital, Ulm Germany
 
5.12
Brain Volumetric Abnormalities in Children and Adolescents with First-Episode Early-Onset Psychosis
Carmen Moreno, M.D. Hospital General Universitario Gregorio Marañón; CIBERSAM, Madrid Spain
Santiago Reig, Ph.D. Hospital General Universitario Gregorio Marañón, Madrid Spain
Mara Parellada, M.D., Ph.D. Hospital General Universitario Gregorio Marañon, Madrid Spain
Josefina Castro, M.D., Ph.D. Hospital Clínico, Barcelona Spain
Joost Janssen, Ph.D. Hospital General Universitario Gregorio Marañón, Madrid Spain
Dolores M. Moreno, M.D., Ph.D.
Inmaculada Baeza, M.D., Ph.D. Hospital Clínico, Barcelona Spain
Ana Maria Gonzalez-Pinto, M.D., Ph.D. Osakidetza Spain
Montserrat Graell, M.D., Ph.D. Hospital Niño Jesús, Madrid Spain
Nuria Bargallo, M.D. Hospital Clínico, Barcelona Spain
Benedicto Crespo, M.D., Ph.D. Spain
Felipe Ortuño, M.D., Ph.D.
Manuel Desco, M.D., Ph.D. Hospital General Universitario Gregorio Marañón, Madrid Spain
Celso Arango, M.D., Ph.D.
 
5.13
Decreased N-Acetyl-Aspartate in the Hippocampus of Juvenile Offenders with Bipolar Disorder
Rene L. Olvera, M.D. University of Texas Health Science Center Department of Psychiatry, San Antonio, TX
Steven R. Pliszka, M.D. University of Texas Health Science Center at San Antonio, San Antonio, TX
Mark Nicoletti, M.S.C.
Jeffrey A. Stanley, Ph.D.
Jair C. Soares, M.D.
 
5.14
A fMRI Study on the Neural Correlates of Response Inhibition in Pediatric Bipolar Disorder and ADHD
Alessandra M. Passarotti, Ph.D. Institute for Juvenile Research, University of Illinois at Chicago, Chicago, IL
Mani N. Pavuluri, M.D., Ph.D. Institute for Juvenile Research, University of Illinois at Chicago, Chicago, IL
John A. Sweeney, Ph.D. University of Illinois at Chicago, Chicago, IL
 
5.15
Neural Mechanisms Involved in the Processing of Monetary Rewards and Losses in Healthy Male Adolescents: An fMRI Study
Celine Relecom, M.D. University Hospital of Geneva; University of Geneva, Chêne-Bourg, Geneva
Fabrice Jollant, M.D.
Stephane Simon, Ph.D.
François Lazeyras, Ph.D.
Alain Malafosse, M.D.
Remy P. Barbe, M.D. SPEA, Carouge Switzerland
 
5.16
Glutamatergic Pathways in Children with and at Risk for Developing Mania
Manpreet K. Singh, M.D. Stanford University, Menlo Park, CA
Daniel Spielman, Ph.D.
Kiki Chang, M.D. Stanford University School of Medicine, Stanford, CA
 
5.17
Effects of Witnessing of Domestic Violence on White Matter Tract Development
Jeewook Choi, M.D., Ph.D. The Catholic University of Korea College of Medicine, Daejeon South Korea
Bumseok Jeong, M.D., Ph.D. Eulji University Hospital, Daejeon South Korea
Michael L. Rohan, M.S.
Ann M. Pocari, Ph.D., R.N.
Martin Teicher, M.D., Ph.D. McLean Hospital, Belmont, MA
 
5.18
Psychiatric Disorders Associated with Scoliosis: A Prevalence Study
Darin Davidson, M.D.
Simon Davidson, M.D. Children's Hospital of Eastern Ontario, Ottawa, ON
Angeliki Perdios, M.S.C.
Christopher Reilly, M.D.
 
5.19
Hippocampal Volumes in the Psychosis Prodrome
Melita L. Daley, M.D. University of California at Los Angeles Semel Institute, Los Angeles, CA
Theo van Erp, Ph.D. Department of Psychology, UCLA, Los Angeles, California
Carrie Bearden, Ph.D. , Los Angeles, CA
Ingrid K. Loesch UCLA Semel Institute, Westwood, CA
Mher Alaverdyan, B.S.
Paul Thompson, Ph.D.
Joseph O'Neill, Ph.D. University of California Los Angeles Semel Institute for Neurosciences, Los Angeles, CA
Arthur Toga, Ph.D.
Tyrone Cannon, Ph.D. UCLA, Los Angeles, CA
 
5.20
Obsessive Compulsive Disorder Symptom Dimensions in Children and Adolescents: An fMRI Study
Andrew R. Gilbert, M.D. University of Pittsburgh School of Medicine, Pittsburgh, PA
Dalila Akkal, Ph.D.
Jorge Almeida, M.D.
Bernie Devlin, Ph.D.
Boris Birmaher, M.D. Western Psychiatric Institute and Clinic, Pittsburgh, PA
Mary L. Phillips, M.D.
 
5.21
Surface Morphology of the Basal Ganglia in Children with ADHD
Loren J. Miller, M.S. New York State Psychiatric Institute, Columbia University; Pritzker School of Medicine, University of Chicago, New York, NY
Juan Sanchez, M.S. RFMH, New York, NY
Kathleen Durkin, M.S.
Shahreen Hossain, B.A.
Jun Liu, Ph.D.
Ravi Bansal, Ph.D. Columbia College of Physicians & Surgeons and the New York State Psychiatric Institute, New York, NY, New york, NY
Bradley S. Peterson, M.D. Columbia University & New York State Psychiatric Institute, New York, NY
 
5.22
MRSI Correlates of Cognitive Behavioral Therapy In Pediatric Obsessive Compulsive Disorder
Joseph O'Neill, Ph.D. University of California Los Angeles Semel Institute for Neurosciences, Los Angeles, CA
John C. Piacentini, A.B.P.P., Ph.D. UCLA, Los Angeles, CA
Susanna Chang, Ph.D.
Michelle Rozenman
Lindsey Bergman, Ph.D.
Noriko Salomon, M.D., Ph.D.
Jeffry R. Alger, Ph.D.
James McCracken, M.D. University of California at Los Angeles/Neuroscience, Psychiatry, and Biobehavior, Los Angeles, CA
 
5.23
Pharmacological fMRI Study: Normalization of Hypofrontality with Lamotrigine in Bipolar Disorder
Mani N. Pavuluri, M.D., Ph.D. Institute for Juvenile Research, University of Illinois at Chicago, Chicago, IL
Alessandra M. Passarotti, Ph.D. Institute for Juvenile Research, University of Illinois at Chicago, Chicago, IL
Melissa Moss, B.A.
John A. Sweeney, Ph.D. University of Illinois at Chicago, Chicago, IL
Erin M. Harral, B.A. University of Illinois at Chicago, Chicago, IL
 
5.24
Metformin for Weight Control in Pediatric Patients on Atypical Antipsychotic Medications
Lauren H. Shin, M.D. Cambridge Health Alliance, Harvard Medical School, Cambridge, MA
Hallie Bregman, B.A.
Janis Breeze, M.P.H.
Nancy Noyes, R.N.
Jean Frazier, M.D. Cambridge Health Alliance, Cambridge, MA
 
5.25
Neuroleptic Malignant Syndrome in Children and Adolescents on Atypical Antipsychotic Medication: A Review
Rachel E. Neuhut, M.D. New York University Medical Center, New York, NY
Jean-Pierre Lindenmayer, M.D.
Raul Silva, M.D. New York University School of Medicine, New York, NY
 
5.26
Response to Antidepressant Treatment in Children and Adolescents with Epilepsy and Depression
Leenu Mishra, M.D. The Cleveland Clinic, Cleveland, OH
Diosely Silveira, M.D. , Cleveland, OH
Damir Janigro, Ph.D.
Eloy Franco, M.D.
Barry Simon, M.D. , Solon, OH
Erin Carlton, B.S.
Tatiana Falcone, M.D. Cleveland Clinic, Shaker Heights, OH
 
5.27
Genome-Wide Association Study of Response to Methylphenidate in 187 Children with ADHD
Eric O. Mick, Ph.D. Massachusetts General Hospital, Boston, MA
Benjamin Neale
Frank A. Middleton, Ph.D.
James J. McGough, M.D. UCLA Semel Institute for Neuroscience and Human Behavior, Los Angeles, CA
Stephen V. Faraone, Ph.D. SUNY Upstate Medical University, Syracuse, NY
 
5.28
Atomoxetine vs. Placebo for the Treatment of ADHD in 5- and 6-Year- Old Children
Christopher J. Kratochvil, M.D. University of Nebraska Medical Center, Omaha, NE
Brigette Vaughan, APRN
Joan Daughton, M.D. , Omaha, NE
Brian Lubberstedt, M.D. , Omaha, NE
Desiree Murray, Ph.D. , Durham, NC
Allan Chrisman, M.D. Duke University Medical Center, Durham, NC
Melissa Faircloth, M.A. Duke University Medical Center, Durham, NC
Nilda Itchon-Ramos, M.S. Duke University Medical Center, Durham, NC
John S. March, M.D., M.P.H. Duke University Child and Family Study Center, Durham, NC
Lawrence A. Maayan, M.D. New York University Child Study Center, Nathan S. Kline Institute for Psychiatric Research, Orangeburg, NY
Laurence L. Greenhill, M.D. New York State Psychiatric Institute, New York, NY
Lisa A. Kotler, M.D. Columbia University and New York State Psychiatric Institute, Englewood, NJ
Jane E. Fried, M.D.
Julie Stoner, Ph.D. University of Oklahoma Health Sciences Center, Oklahoma City, OK
 
5.29
What Should Be the Role of Antipsychotic Medications in the Maintenance Treatment of Youth with Bipolar Disorder?
Vivian Kafantaris, M.D. The Zucker Hillside Hospital, Glen Oaks, NY
Ema Saito, M.D. , New Hyde Park, NY
Carolyn Dombrowski, APRN Private Practice, Hicksville, NY
Alison Berest, B.S. Zucker Hillside Hospital, Glen Oaks, NY
Judith Hirsch, M.D. Zucker Hillside Hospital, Glen Oaks, NY
Ellen Leigh, Ph.D. Laurel Hill Inn, Medford, MA
Kim Gallelli, Ph.D. Private Practice, Mill Valley, CA
Jory Wixsom, M.D. Zucker Hillside Hospital, Glen Oaks, NY
Sanjiv Kumra, M.D. , Woodbury, MN
John Kane, M.D. Zucker Hillside Hospital, Glen Oaks, NY
 
5.30
Serum Levels of Olanzapine: Intraindividual Variability in Adolescent Patients
Michael Haberhausen, M.D. University of Marburg, Marburg Germany
Christian Bachmann, M.D.
Frank Theisen, Ph.D.
 
5.31
A Phase IV, Double-Blind, Placebo-Controlled, Randomized, Flexible-Dose Study of Selegiline Transdermal System (EMSAM) for the Treatment of Adolescents with Major Depression: An Interim Safety Report
Jayasree J. Nandagopal, M.D. University of Cincinnati, Cincinnati, OH
Thomas J. Hochadel, PharmD Cognitive Research Corporation, St. Petersburg, FL
Eva Kemper, M.S.H.S. Cognitive Research Corporation, St. Petersburg, FL
Melvin Sharoky, M.D. Somerset Pharmaceuticals, Tampa, FL
Melissa L. Goodhead, B.Sc. Somerset Pharmaceuticals, Tampa, FL
Melissa P. DelBello, M.D. University of Cincinnati College of Medicine, Cincinnati, OH
 
5.32
Measurement of Impulsivity in Adolescents with Bipolar Disorder Versus Adolescents with ADHD
Jayasree J. Nandagopal, M.D. University of Cincinnati, Cincinnati, OH
Melissa P. DelBello, M.D. University of Cincinnati College of Medicine, Cincinnati, OH
David E. Fleck, Ph.D.
Michael Cerullo, M.D.
Neil P. Mills, B.S.
Stephen M. Strakowski, M.D.
 
5.33
Sources of Diagnostic Variability in Pediatric Bipolar Disorder Diagnostic Instruments
Cathryn A. Galanter, M.D. Columbia University and New York State Psychiatric Institute, New York, NY
Prudence W. Fisher, Ph.D. New York State Psychiatric Institute, New York, NY
 
5.34
A Scale to Assist the Diagnosis of Autism Spectrum Disorders in Adults (The RAADS): Preliminary Results of a Multi-Center Standardization Study
Edward Ritvo, M.D. University of California at Los Angeles, School of Medicine, Los Angeles, CA
R. Ariella Ritvo, Ph.D. , Los Angeles, CA
Max Ritvo , Los Angeles, CA
Donald Guthrie, Ph.D.
 
5.35
Is the DSM-IV Anxiety Disorders Classification Scheme Valid in Hispanic/Latino Youth?
Alexander G. Perez, M.D. University of Miami; Jackson Memorial Hospital Division of Child and Adolescent Psychiatry, Miami, FL
Yasmin Rey, M.S. Florida International University, Miami, FL
Melissa M. Nieves, B.A. Florida International University, Miami, FL
Wendy K. Silverman, Ph.D. Florida International University, Miami, FL
 
5.36
A Virtual Adolescent Patient with Posttraumatic Stress Disorder for Training Psychiatrists
Caroly Pataki, M.D. University of Southern California, Keck School of Medicine, Los Angeles, CA
Jeff Sugar, M.D. , El Segundo, CA
Patrick Kenny
Thomas D. Parsons, Ph.D.
Albert A. Rizzo, Ph.D.
Michele Pato, M.D.
Cheryl St. George, R.N.
James Piacentini, B.A.
 
5.37
An Evaluation of a Computerized Psychoeducational Prevention Program for the Risk Factors Associated with Eating Disorders in Adolescents
Deirdre R. Ryan, B.S. University College Dublin, Dublin Ireland
Barbara Dooley, Ph.D.
Alison M. Darcy, Ph.D. Stanford University School of Medicine, Stanford, CA
 
5.38
Psychopathology in the Offspring of Parents with Bipolar Disorder, Schizophrenia, and Healthy Controls in a Spanish Sample: A Preliminary Comparison Study
Soledad Romero, M.D. Hospital Clinic Barcelona, Barcelona Spain
Margarita Garcia-Amador, M.D. , New York, NY
Elena de la Serna, M.A. Hospital Clínico, Barcelona Spain
Vanessa Sanchez, M.D. Hospital Clínico, Barcelona Spain
Inmaculada Baeza, M.D., Ph.D. Hospital Clínico, Barcelona Spain
Susana Andres, Ph.D. Hospital Clínico, Barcelona Spain
Luisa Lázaro, M.D., Ph.D. Hospital Clínico, Barcelona Spain
Josefina Castro, M.D., Ph.D. Hospital Clínico, Barcelona Spain
 
5.40
Early and Late Application of a Psychoeducative Program In Adolescents: Comparative Study
Liz Sosa, M.D. National Institute of Psychiatry, Mexico City Mexico
Lino Palacios, M.D. , Mexico City Mexico
Miriam Feria, M.D.
Rosa Elena Ulloa, M.D. , Mexico City Mexico
Francisco De La Pena, M.D. , Mexico City Mexico
 
5.41
Understanding Cost and Capacity in An English Child and Adolescent Mental Health Service
Sachin Sankar, MBBS Northampton General Hospital, Northampton United Kingdom
 
5.42
A Cross-Sectional Study of Sleep Duration and Sleep Problems in Korean Children
Wan Seok Seo, M.D. Yeungnam University, Daegu, Kyungbuk
Hyung Mo Sung, M.D. Dept. of psychiatry, Pochon CHA university/Kumi CHA hospital, Kumi South Korea
Bon Hoon Koo, M.D.
 
5.43
An Exploration of the Relationship Between Parental Psychopathology and Symptom Severity in Adolescent Anorexia Nervosa
Sarah Forsberg, B.A. Stanford University, Stanford, CA
Sheila Ravi, M.D.
Kathleen K. Fitzpatrick, Ph.D. Stanford University, Stanford, CA
James D. Lock, M.D. Stanford Univ. School of Medicine, Standford, CA
 
5.44
Predictors of Bullying in Black and White Adolescent Males
Jessica Adler, M.D. St. Luke's-Roosevelt Hospital Center, New York, NY
Michelle C. Acosta, Ph.D.
Ramon Solhkhah, M.D. St. Luke's-Roosevelt Hospital Center, New York, NY
 
5.45
Use of Video Games as a Risk Factor for Aggressive Behavior and Parents' Supervision as a Protective Factor in a Clinical Sample of Latino Adolescents
Luz N. Colón, M.D. University of Puerto Rico, San Juan, PR
Roberto Gutiérrez, M.D.
Alexis González, M.D.
 
5.46
A Pilot Study of Aggression Subtype in Seriously Emotionally Disturbed Adolescent Girls
Asma Rashid, MBBS, M.P.H. University of Connecticut, Hartford, CT
Sadaf M. Hashmi, MBBS, M.P.H.
Josephine Hawke, Ph.D.
Geraldine S. Pearson, Ph.D., R.N. University of Connecticut School of Medicine, Farmington, CT
Daniel Connor, M.D. University of Connecticut Health Center, Farmington, CT
 
5.47
Adolescent Antisocial Personality Disorder Symptoms, Five-Factor Model of Personality Facet Traits, and the Prediction of Delinquency
Yann D. Le Corff, M.A. University of Sherbrooke, Sherbrooke, PQ
Jean M. Toupin, Ph.D. University of Sherbrooke, Sherbrooke, PQ
 
5.48
Complex Trauma in the Child Welfare System: Initial Clinical Presentation and Treatment Response
Nneka E. Onyezia, B.A. Northwestern University, Chicago, IL
 
5.49
Cultural Sensitivity in Dissemination of a Manualized Parent Training Program
Lawrence A. Vitulano, Ph.D. Yale University Child Study Center, Fairfield, CT
Michael L. Vitulano, B.A. Massachusetts General Hospital, Boston, MA
Karen Bearss, Ph.D.
 
5.50
Measuring Alexithymia in a Healthy Pediatric Population
Miya R. Asato, M.D. University of Pittsburgh School of Medicine, Pittsburgh, PA
Brenda Bursch, Ph.D. David Geffen School of Medicine at UCLA, Los Angeles, CA
Prabha Siddarth, Ph.D. University of California at Los Angeles, Los Angeles, CA
Beatriz Luna, Ph.D. , Pittsburgh, PA
Jay Salpekar, M.D. Children's National Medical Center, Washington, DC
Joan K. Austin, R.N. Indiana University School of Nursing, Indianapolis, IN
Rochelle Caplan, M.D. University of California at Los Angeles Neuropsychiatric Hospital, Los Angeles, CA
 
5.51
Behavioral, Cognitive, and Academic Correlates of the BRIEF Symptom Scale
Tara McAuley, M.A. The Hospital for Sick Children, Toronto, ON
Jennifer Crosbie, Ph.D. The Hospital for Sick Children, Toronto, ON
Shirley Chen, M.D., M.P.H.
Lisa Goos, Ph.D. , Toronto, ON
Russell Schachar, M.D., F.R.C.P. University of Toronto, Toronto, ON
 
5.52
Presenting ADHD Symptoms and Subtypes in Clinically Referred Adults with ADHD
Timothy Wilens, M.D. Massachusetts General Hospital, Boston, MA
Stephen V. Faraone, Ph.D. SUNY Upstate Medical University, Syracuse, NY
Joseph Biederman, M.D. Massachusetts General Hospital, Boston, MA
Michael L. Vitulano, B.A. Massachusetts General Hospital, Boston, MA
Diana Westerberg, B.A.
Thomas J. Spencer, M.D. , Boston, MA
 
5.53
Before School ADHD Symptoms and Functioning in Youth Treated with Transdermal Methylphenidate
Timothy Wilens, M.D. Massachusetts General Hospital, Boston, MA
Paul G. Hammerness, M.D. Massachusetts General Hospital, Cambridge, MA
Linsey Utzinger, B.A.
Anna Georgiopoulos, M.D.
Robert L. Doyle, M.D.
Joseph Biederman, M.D. Massachusetts General Hospital, Boston, MA
 
5.54
The Influence of Comorbid Conduct Disorder on Substance Use Disorders in Adolescents with Bipolar Disorder
Timothy Wilens, M.D. Massachusetts General Hospital, Boston, MA
Joel Adamson Massachussetts General Hospital, Boston, MA
Tiffany Parcell, B.S.
Diana Westerberg, B.A.
Joseph Biederman, M.D. Massachusetts General Hospital, Boston, MA
 
5.55
Temperament and Psychopathological Profiles of Oppositional Defiant Disorder with or without ADHD
Hyo-Won Kim, M.D. Seoul National University Hospital, Seoul South Korea
Soo-Churl Cho, M.D., Ph.D. Seoul National University Hospital, Chongro-Gu, Seoul, Seoul
Boong-Nyun Kim, M.D., Ph.D. Seoul National University, Seoul South Korea
Jae-Won Kim, M.D., Ph.D. Seoul National University Hospital, Seoul South Korea
Min-Sup Shin, Ph.D. Department of Child and Adolescent Psychiatry, College of Medicine, Seoul National University, Seoul South Korea
 
5.56
Biogenetic Temperament and Character Profiles and ADHD Symptoms in Korean Adolescents with Problematic Internet Use
Jae-Won Kim, M.D., Ph.D. Seoul National University Hospital, Seoul South Korea
Boong-Nyun Kim, M.D., Ph.D. Seoul National University, Seoul South Korea
Soo-Churl Cho, M.D., Ph.D. Seoul National University Hospital, Chongro-Gu, Seoul, Seoul
 
5.57
Long-Term Sustained Benefits of Clozapine Treatment in Refractory Very Early-Onset Schizophrenia: A Retrospective Study in Korean Children and Adolescents
Yeni Kim, M.D., Ph.D. Seoul National University; Boramae Hospital, Seoul South Korea
Boong-Nyun Kim, M.D., Ph.D. Seoul National University, Seoul South Korea
Soo-Churl Cho, M.D., Ph.D. Seoul National University Hospital, Chongro-Gu, Seoul, Seoul
Jae-Won Kim, M.D., Ph.D. Seoul National University Hospital, Seoul South Korea
Min-Sup Shin, Ph.D. Department of Child and Adolescent Psychiatry, College of Medicine, Seoul National University, Seoul South Korea
 
5.58
A Controlled Study of Olanzapine in Autism: Study Design and Screening Failures
Richard P. Malone, M.D. Drexel University College of Medicine, Philadelphia, PA
Mary A. Delaney, M.D. , Lower Gwynedd, PA
Susan B. Hyman, Ph.D.
H. H. Hardison, M.D.
 
5.59
Risperidone for the Treatment of Conduct Disorder in Preschool Children with Average Intelligence
Eyup Sabri Ercan, M.D. Ege University Medical Faculty, Izmir Turkey
Burge K. Basay, M.D. Ege University Medical Faculty, Izmir Turkey
Omer Basay, M.D. Ege University Medical Faculty, Izmir Turkey
Sibel Durak, M.D. Karsýyaka State Hospital, Izmir Turkey
 
5.60
Frequency and Predictors of Medication Non-Adherence in Patients Seen in a Pediatric Psychiatric Emergency Room
Erin Reis Callahan, M.D. Columbia University Medical Center, New York, NY
Christoph U. Correll, M.D. Zucker Hillside Hospital, Glen Oaks, NY
See more of: New Research Poster